Concepedia

Andrzej Mital

AM

Statistics

Publications

21

Citations

1.2K

H-Index

14

Active since

1989

Affiliations

Gdańsk Medical University(Current)

Medical University of Lodz

Medical University of Silesia

Poznan University of Medical Sciences

Columbia University Irving Medical Center

Andrzej Mital is an author at Gdańsk Medical University specializing in medicine, pharmacology, and hematology.

ORCID

Publications per year

1989–2024

21

Publications

21

Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

Jennifer R. Brown, Barbara Eichhorst, Peter Hillmen et al. · New England Journal of Medicine · 2022 · 457 citations · Full text

, , +16

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Jason Gotlib, Andreas Reiter, Deepti Radia et al. · Nature Medicine · 2021 · 147 citations · Full text

, , +12

Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial

Peter Hillmen, Barbara Eichhorst, Jennifer R. Brown et al. · Journal of Clinical Oncology · 2022 · 93 citations · Full text

, , +15

Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE

Jennifer R. Brown, Barbara Eichhorst, Nicole Lamanna et al. · Blood · 2024 · 61 citations · Full text

, , +3

Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients

Andrzej Mital, Witold Prejzner, Maria Bieniaszewska et al. · Polskie Archiwum Medycyny Wewnętrznej · 2015 · 57 citations · Full text

, , +13

1–5 of 21